Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 4,176 | 2,832 | 2,233 | 1,439 | 2,009 |
| Cost of Goods | 1,214 | 1,044 | 812 | 573 | 1,020 |
| Gross Profit | 2,962 | 1,788 | 1,421 | 866 | 989 |
| Operating Expenses | 11,521 | 10,830 | 10,075 | 9,316 | 9,826 |
| Operating Income | -8,345 | -8,998 | -7,842 | -7,877 | -8,817 |
| Interest Expense | 0 | 0 | -422 | 0 | 0 |
| Other Income | 3,160 | -190 | 520 | 1,332 | -75 |
| Pre-tax Income | -5,185 | -9,188 | -6,900 | -6,545 | -8,892 |
| Income Tax | -238 | 177 | 19 | 40 | -229 |
| Net Income Continuous | -4,947 | -9,365 | -6,919 | -6,585 | -8,663 |
| Net Income | $-4,947 | $-9,365 | $-6,919 | $-6,585 | $-8,663 |
| EPS Basic Total Ops | -0.19 | -0.38 | -0.28 | -0.27 | -0.41 |
| EPS Basic Continuous Ops | -0.19 | -0.38 | -0.28 | -0.27 | -0.41 |
| EPS Diluted Total Ops | -0.19 | -0.38 | -0.28 | -0.27 | -0.41 |
| EPS Diluted Continuous Ops | -0.19 | -0.38 | -0.28 | -0.27 | -0.41 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.38 | -0.28 | N/A | N/A |
| EBITDA(a) | $-8,107 | $-8,784 | $-7,608 | $-7,627 | $-8,735 |